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Abstract
Epigenetic modifications of cytosine residues in the DNA play a critical role for cellular differentiation and potentially also for
aging. In mesenchymal stromal cells (MSC) from human bone marrow we have previously demonstrated age-associated
methylation changes at specific CpG-sites of developmental genes. In continuation of this work, we have now isolated
human dermal fibroblasts from young (,23 years) and elderly donors (.60 years) for comparison of their DNA methylation
profiles using the Infinium HumanMethylation27 assay. In contrast to MSC, fibroblasts could not be induced towards
adipogenic, osteogenic and chondrogenic lineage and this is reflected by highly significant differences between the two cell
types: 766 CpG sites were hyper-methylated and 752 CpG sites were hypo-methylated in fibroblasts in comparison to MSC.
Strikingly, global DNA methylation profiles of fibroblasts from the same dermal region clustered closely together indicating
that fibroblasts maintain positional memory even after in vitro culture. 75 CpG sites were more than 15% differentially
methylated in fibroblasts upon aging. Very high hyper-methylation was observed in the aged group within the INK4A/ARF/
INK4b locus and this was validated by pyrosequencing. Age-associated DNA methylation changes were related in fibroblasts
and MSC but they were often regulated in opposite directions between the two cell types. In contrast, long-term culture
associated changes were very consistent in fibroblasts and MSC. Epigenetic modifications at specific CpG sites support the
notion that aging represents a coordinated developmental mechanism that seems to be regulated in a cell type specific
manner.
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Introduction
There is a growing perception that epigenetic modifications,
such as DNA methylation and histone modification, play an
important role for cellular senescence and aging of the organism
[1–3]. CpG dinucleotides in the genomic DNA can be methylated
at cytosine moieties. Upon replication the same methylation
pattern is established on the newly synthesized DNA strand by
DNA methyltransferase 1 (DNMT1) and thereby, the methylation
pattern is inherited to both daughter cells. This inheritance of
epigenetic modifications might provide an ideal mechanism for the
regulation of progressive alterations in the course of aging [4].
Various studies have indicated, that the global DNA methyl-
ation level decreases upon aging in murine, rat and human tissues
[5–7]. It was also shown that the 5-methylcytosine content
decreased upon long-term culture of fibroblasts [8]. This led to
the suggestion that the global loss of DNA methylation might be a
result of passive demethylation as a consequence of a progressive
loss of DNMT1a efficiency [9]. However, a number of specific loci
become hyper-methylated during aging, such as the INK4A/ARF/
INK4b locus, the ribosomal gene cluster, estrogen receptor (ER), runt-related
transcription factor 3 (RUNX3), insulin growth factor II (IGF2), E-cadherin,
c-fos and others [1,10–13]. These specific changes indicate that
age-associated methylation changes are not simply based on
random deterioration during ontogenic development although it is
yet unknown how site-specific methylation changes are regulated.
We have recently analyzed age-associated DNA methylation
changes in human mesenchymal stromal cells (MSC) [14]. These
cells comprise multipotent precursors for mesodermal cell lineages
such as osteocytes, chondrocytes and adipocytes and have
therefore been coined as ‘‘mesenchymal stem cells’’. Global
methylation profiles were analyzed using the HumanMethyla-
tion27 BeadChip microarray allowing the determination of DNA
methylation levels at 27,578 unique CpG sites within more than
14,000 promoter regions. Overall, methylation patterns of MSC
were maintained throughout both, long-term culture and aging,
whereas highly significant differences were observed at specific
CpG sites. Notably, methylation changes as well as gene
expression changes in MSC were overlapping in long-term culture
in vitro and aging in vivo [14–17]. This supports the notion of
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tal processes, regulated by specific epigenetic modifications.
Distinct age-related phenotypes, such as wrinkle formation, hair
graying and impaired wound healing, as well as the accessibility of
samples from differently aged healthy donors make human skin an
ideal model system for the analysis of age-related epigenetic
changes [18,19]. Dermal fibroblasts are important for skin
architecture and extracellular matrix (ECM) synthesis and they
are morphologically indistinguishable from MSC preparations. It
is controversially discussed if immunomodulatory capacities and
differentiation potential vary between the two cell types - some
studies indicated that dermal fibroblasts display similar in vitro
differentiation potential as MSC [20–22]. This might be explained
by the finding that human dermal fibroblasts are composed of
different subtypes with distinct gene expression profiles according
to the anatomical site of origin [23]. With this in mind, we have
isolated fibroblasts from different dermal regions to investigate
age-associated changes in their DNA methylation profiles in
comparison to MSC.
Results
Comparison of dermal fibroblasts with bone marrow
MSC
Human dermal fibroblasts were isolated from young (6–23 years
old; 9 samples) and elderly donors (60–73 years old; 6 samples).
Mesenchymal stromal cells were isolated from bone marrow of
young (21–50 years old; 4 samples) and elderly donors (53–85
years old; 4 samples) as described in our previous work [14,16].
Both cell types revealed a very similar spindle-shaped morphology
and growth pattern. Furthermore, fibroblasts and MSC displayed
the same and uniform immunophenotype for surface markers that
are commonly used for the definition of MSC (CD142, CD29+,
CD312, CD342, CD452, CD73+, CD90+, CD105+;
Figure 1A). Simultaneous in vitro differentiation revealed that
adipogenic differentiation could be induced in about 40% of the
cells within MSC preparations, whereas hardly any fat droplet
formation was observed in fibroblasts (n=5, Figure 1B,E).
Osteogenic differentiation induced calcific deposition only in
MSC but not in fibroblasts (Figure 1C,F) and chondrogenic
differentiation in micromass culture induced sulfated glycosami-
noglycan rich matrix only in MSC but not in fibroblasts
(Figure 1D). These results support the notion, that MSC but not
fibroblasts comprise a multipotent subset of progenitor cells.
DNA methylation changes between fibroblasts and MSC
DNA methylation profiles of fibroblasts and MSC of early
passage (passage 3 and passage 2 respectively) were compared
using the HumanMethylation27 BeadChip microarray. Hierar-
chical cluster analysis clearly separated fibroblasts and MSC into
two different groups (Figure 2A) and histograms of P-values
demonstrate a skew towards 0 which supports the notion of a high
number of significant differences (Figure S1A). Various CpG sites
revealed differences in average beta greater than 0.15 (referred to
as more than 15% difference in methylation level) between
fibroblasts and MSC and additionally passed a second filter
criterion of highly significant changes (P,0.001 with limma
moderated T-test): 766 CpG sites were hyper-methylated in
fibroblasts whereas 752 CpG sites were hypo-methylated. These
CpG sites corresponded to 521 and 499 non-redundant genes that
were categorized by Gene Onthology classification. Hyper-
methylated CpG sites in fibroblasts were significantly over-
represented in genes of categories that mediate development,
immune response and hormone secretion. Hypo-methylated genes
were rather involved in immune response, defense response and
wound healing (Figure S2). Taken together, fibroblasts and MSC
differ in their epigenetic profiles and this may result in their
dissimilar differentiation potential and immunomodulatory func-
tion.
Epigenetic positional memory of fibroblasts
It was striking that DNA methylation profiles of fibroblasts
from the same dermal region such as ear, arm, breast, abdomen
or leg clustered always closely together in hierarchical cluster
analysis (Figure 2A). To depict differences that lead to the
clustering, we selected 3182 CpG sites that might be differen-
tially methylated among anatomical sites (P,0.001; limma
moderated F-statistic). These CpG sites were then subjected to
a heatmap (Figure S3). Differences in fibroblasts from different
anatomical sites are further supported by principal components
analysis (PCA; Figure 2B). Such positional memory might be
governed by epigenetic modification of homeobox containing or
HOX-genes that have been shown to be important for patterning
the primary and secondary axes [24,25]. Hierarchical clustering
of 85 CpG sites represented on the microarray that are
associated with the four HOX clusters revealed methylation
changes that correlate with different anatomical sites (Figure S4).
Thus, fibroblasts and MSC maintain positional information in
their DNA methylation profile even after culture expansion for
three passages.
Age-associated DNA methylation changes in fibroblasts
Comparison of DNA methylation profiles in fibroblasts derived
from young (,23 years old) or elderly donors (.60 years old)
revealed that 75 CpG sites change their methylation level more
than 15% upon aging (Figure 3A). However, none of these were
highly significant using the stringent criteria as mentioned above
(P,0.001; limma moderated T-test). This might be due to the
relatively small sample number or other parameters which may
impact differential methylation. Alternatively, we performed pair
wise comparisons with fibroblasts from the same dermal location
to exclude bias by sampling from different anatomical sites, and
these results were very similar (data not shown). Only skin samples
from female donors were utilized to avoid DNA methylation
differences due to dose compensation of sex chromosomes [19].
On the other hand, there is a tendency towards zero in the
histogram of P-values indicating that there might be specific age-
associated changes (Figure S1B,C). We used rank product
(RankProd) test as alternative non-parametric method to generate
adjusted p-values and 257 CpG sites reached a significance level
below 0.05. These included 31 CpG sites of the 75 CpG sites with
methylation changes of more than 15% (Table S1).
Genes with CpG sites that revealed the highest age-associated
hyper-methylation included sperm associated antigen 7 (SPAG7; 26%),
cyclin-dependent kinase inhibitor 2B (CDKN2B; 26%) and Stannin (SNN;
20%). In contrast, genes with hypo-methylated CpG sites included
aldehyde dehydrogenase 1A1 (ALDH1A1; 230%); complement factor D
(CFD; 222%); WNT1 inducible signaling pathway protein 2 (WISP2;
218%) and cyclin-dependent kinase 5, regulatory subunit 1 (CDK5R1;
217%). Subsequently, we have tested how differential DNA
methylation is reflected on gene expression level: quantitative real
time PCR of 7 genes demonstrated that in tendency, hypomethy-
lation upon aging is associated with higher gene expression and
this was significant for WISP2, ALDH1A1 and CFD (Figure S5).
Other authors indicated that the global methylation level decays
upon aging. Therefore, we reanalyzed non-quantil normalized
raw-data and there was a slight decline of the methylation level
upon aging in fibroblasts (Figure S6). The 90-quantil of
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younger donors whereas it was 78.5% in fibroblasts from elderly
donors (P=0.02). In contrast, global age-associated hypomethyla-
tion was not significant in MSC (P=0.93). 1060 CpG sites were
more than 15% differentially methylated in MSC of young and
elderly donors [14] (Figure 3B). There was no linear correlation in
age-associated changes in fibroblasts and MSC. Strikingly, 30
CpG sites were in the overlap of CpG sites with age-associated
changes in fibroblasts and MSC (Figure 3C, Table S2). Thus, 40%
of age-associated changes in fibroblast CpG sites were also
differentially methylated in MSC and hypergeometric distribution
revealed that this association is highly significant (P,10
225).
Figure 1. Molecular characterization of fibroblasts and MSC. Dermal fibroblast and mesenchymal stromal cells from bone marrow display a
very similar immunophenotype (A). Adipogenic differentiation could not be induced in fibroblasts whereas fat droplet formation was observed in
about 40% of the MSC upon differentiation (B,E; blue: DAPI; green: BODIPY; scale bar: 100 mm). Osteogenic differentiation was monitored by Alizarin
Red staining of calcium phosphate precipitates and this could only be induced in MSC but not in fibroblasts (C,F; scale bar: 100 mm). Chondrogenic
differentiation was analyzed by Alcian Blue staining of glucosaminoglycans in micromass culture and this was again only observed in MSC but not in
fibroblasts (D; scale bar: 50 mm).
doi:10.1371/journal.pone.0016679.g001
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fibroblasts were hypo-methylated upon aging of MSC and vice
versa.
Age-associated methylation changes wereanalyzedinmore detail
for CDKN2B that is part of the INK4A/ARF/INK4b locus. Notably,
all 6 CpG sites within the second exon of CDKN2B represented on
Figure 2. Relationship of DNA methylation profiles. DNA methylation profiles of fibroblasts and MSC were analyzed with the
HumanMethylation27 BeadChip that facilitates simultaneous analysis of 27,578 unique CpG sites. Unsupervised hierarchical clustering (Euclidian
distance) of all CpG sites separated fibroblasts and MSC in two different groups. Furthermore, cell preparations from the same anatomical site clustered
together (A). Alternatively, we used principal components analysis (PCA) to visualize the relationship of fibroblasts from different dermal regions (B).
doi:10.1371/journal.pone.0016679.g002
Figure 3. Age-associated methylation changes in fibroblasts and MSC. Mean DNA methylation of 27,578 CpG sites was compared between
fibroblasts from young donors (,23 years, eight samples) and from elderly donors (.60 years; six samples) by scatter plot analysis. 75 CpG sites
revealed more than 15% age-associated differential methylation (indicated as black spots; A). Scatterplot analysis of MSC from young (,50 years, four
samples) and elderly donors (.50 years, four samples) demonstrated that 1060 CpG have more than 15% age-associated DNA methylation changes
(B). Comparison of fibroblasts revealed that 30 CpG sites were overlapping differentially methylated upon aging in MSC and fibroblasts (black spots;
C). This is highly significantly more than expected by chance alone but differential methylation often occurred in opposite directions.
doi:10.1371/journal.pone.0016679.g003
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methylated upon aging in fibroblasts, whereas they were hypo-
methylated in MSC. These age-associated DNA methylation
changes were exemplarily validated by pyrosequencing and this
method revealed very similar age-associated methylation changes in
five neighboring CpG sites (Figure 4). Taken together, there are
someage-associated DNAmethylationchangesat specificCpG sites
in fibroblasts and MSC but they are often regulated in opposite
directions in a cell type dependent manner.
Replicative senescence affects DNA methylation patterns
Long-term culture of MSC has impact on proliferation, cell size
and differentiation potential [26] and we have recently demon-
strated that this is associated with reproducible and highly
significant DNA methylation changes at specific CpG sites [14].
To determine if similar epigenetic modifications are induced by
long-term culture of fibroblasts, we have compared DNA
methylation profiles of passage 3 and passage 21 of fibroblasts (6
year old donor, othoplastic). Comparison of long-term culture
associated DNA methylation changes in fibroblasts and MSC
revealed a striking correlation in CpG sites that were more than
15% differentially methylated in both cell types (P,10
231, chi-
square analysis of 161 CpG sites; Figure 5A). Thus, replicative
senescence induces similar hyper-methylation and hypo-methyla-
tion at specific CpG sites in fibroblasts and MSC. Furthermore,
there was a significant correlation between DNA methylation
changes in fibroblasts upon long-term culture in vitro and aging in
vivo (P=0.001, chi-square analysis of 32 CpG sites with more than
15% methylation changes in both comparisons; Figure 5B).
Discussion
Fibroblasts are diverse with various functions in different dermal
regions [23]. This diversity is also reflected in global DNA
Figure 4. Age-associated DNA methylation changes in CDKN2B. Cyclin-dependent kinase inhibitor 2B (CDKN2B) belongs to the INK4A/ARF/
INK4B locus and six CpG sites within the second exon are represented by the microarray (A). All of these were hyper-methylated upon aging in
fibroblasts (B) and they were all hypo-methylated in MSC (C). Pyrosequencing of five neighbouring CpG sites in this region verified significant hyper-
methylation upon aging in fibroblasts (D) and hypo-methylation in MSC (E). * P,0.05; ** P,0.01; *** P,0.001).
doi:10.1371/journal.pone.0016679.g004
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sites provide a positional memory of the sampling location and
there are age-associated DNA methylation changes that may
contribute to aging of the skin.
The question, how to distinguish between fibroblasts and MSC,
is not trivial. MSC raise high hopes for cellular therapy and
regenerative medicine and they are concurrently tested in various
clinical trials [27]. Despite intensive research over the last decade,
there is still no molecular definition of multipotent subsets. MSC
and fibroblasts are very similar in cell size, morphology, growth
pattern and immunophenotype [28–30]. Traditionally, MSC have
been defined by their multipotent differentiation potential [31,32]
but this demarcation has lost its clarity since it has been shown,
that human dermal fibroblasts may also comprise multipotent cells
with adipogenic, osteogenic and chondrogenic differentiation
potential [33,34]. However, for the samples used in this study,
adiopogenic and osteogenic differentiation could only be induced
in MSC but not fibroblasts. Hence, the difference in DNA
methylation profiles between fibroblasts and MSC may also arise
from a specific epigenetic make up of the multipotent subset within
MSC. Further MSC preparations isolated under different culture
conditions and other cell types need to be considered to determine
epigenetic modifications that are characteristic for adult stem cells
[32].
Reciprocal epithelial-mesenchymal interactions shape site-
specific development of the skin. Recombination experiments in
chick suggested that dermal signals dictate positional identity of
epidermal differentiation: for example transplantation of wing
epithelium to leg mesenchyme transforms the development of
feathers to the development of scales [35,36]. Various studies have
addressed the anatomic diversity of human fibroblasts on the gene
expression level [23,36,37]. These datasets demonstrated the
association of global gene expression profiles with the site of
fibroblast origin and they were related to three anatomic divisions:
anterior - posterior, proximal - distal and dermal versus non-
dermal. It has also been shown, that site-specific HOX expression
in fibroblasts maintains features of the embryonic HOX pattern
over decades in vivo and over numerous cell divisions in vitro [36].
In this study, we demonstrate that fibroblasts also maintain an
epigenetic positional memory even after culture expansion for
three passages. Hierarchical clustering of CpG sites related to
HOX genes revealed a separation of fibroblasts from the top half
(anterior) versus the bottom half (posterior) of the human body.
Recently it has been shown, that variably methylated regions
(VMRs) exist in the genome which are highly variable in DNA-
methylation among individuals [38]. Several of these were in
developmental genes including HOX genes and therefore inter-
individual differences in fibroblast CpG methylation may act as a
potential contributor to the site-dependent structure. Thus, a
larger number of samples from various regions will be necessary to
gain further insight into the systematics of positional determination
by epigenetic modifications. This might also be useful for forensic
analysis of tissue samples of unknown origin.
Various molecular mechanisms have been implicated in aging
including telomere-shortening, accumulation of mutations, oxida-
tive stress and alteration of molecular pathways [39]. Decreases in
the global level of methylation along with a concomitant increase
in promoter methylation has become a hallmark of age-associated
epigenetic changes [5–7,40]. Decrease of the 5-methylcytosine
content upon aging has been demonstrated almost 40 years ago in
the brain, heart and spleen of rats [6] and there is even evidence,
that the global methylation level changes upon aging in plants
[41]. In this study, we observed only a moderate age-associated
hypo-methylation in fibroblasts. This might be due to the bias for
promoter regions within the 27,578 CpG sites represented on the
microarray whereas it has been shown, that hypo-methylation
upon aging occurs predominantly in specific interspersed repetitive
sequences (IRSs) [42]. Age-associated DNA methylation changes
appear to be more complex as methylation of specific CpG sites
reveal directional perturbations [12,43,44]. For example, Chris-
tensen et al. provided clear evidence of tissue–specific methylation
changes related to aging [43].
Figure 5. Long-term culture-associated methylation changes in fibroblasts and MSC. Differential methylation between passage 3 and
passage 21 of fibroblasts (6 year old donor) was plotted against differential DNA methylation data upon long-term culture of MSC that has been
described before [14] (A). Black spots demonstrate CpG sites with differential methylation of more than 15% upon long-term culture of both cell
types and these showed a very good correlation in long-term culture associated changes in fibroblasts and MSC (R=0.764). We have also compared
long-term culture-associated DNA methylation changes and age-associated changes in fibroblasts and they display only moderate correlation
(R=0.337; B).
doi:10.1371/journal.pone.0016679.g005
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CDKN2B) plays a pivotal role in aging and cancer [45]. Gene
expression of p16
INK4A (CDKN2A) increases with age and it has
even been proposed as a biomarker of aging [46]. Furthermore,
functional studies in hematopoietic stem cells, neuronal stem cells
and pancreatic islets have suggested, that p16
INK4A is one cause of
aging by down-regulation of self-renewal potential of adult stem
cells [46–48] and reprogramming towards induced pluripotent
stem cells is critically dependent on the repression of p19
ARF in
mice and p16
INK4A in humans [49]. In this study, we observed the
second-highest hyper-methylation upon aging of fibroblasts in
CDKN2B. However, it is intriguing that the same CpG sites are
hypo-methylated upon aging in MSC.
Overall, age-associated DNA methylation changes occurred at
similar CpG sites upon aging in fibroblasts and MSC, but they
were often regulated in different directions. This may underline
the functional difference between the two cell types and the
involvement of different mechanisms for cellular aging. It is also
conceivable, that epigenetic modifications are differently regulated
by the diverse cellular microenvironments in dermis and bone
marrow. In our analysis, ages in fibroblasts and MSC were not
matched and aging in MSC might be biased by the different
available sources of bone marrow in young and elderly donors as
described before [14]. All the more, the significant interrelation of
age-associated methylation changes in fibroblasts and MSC is
noteworthy. Recently, polycomb group protein targets have been
shown to become far more likely methylated with age [13].
Furthermore, hyper-methylation occurs predominantly at bivalent
chromatin domain promoters in CD4+ T-cells and CD14+
monocytes [12]. These are developmentally regulated genes
harboring both, activating (H3K4me3) and inactivating
(H3K27me3) histone marks in embryonic stem cells [50–52].
The bivalent epigenetic modifications raise the possibility of age-
associated genes being poised in a bipotential state, which may be
resolved differently in various cell lineages. This might explain the
opposing age-associated DNA methylation changes in different
tissues [43] and between fibroblasts and MSC.
Replicative senescence upon long-term culture is not an
inevitable fate of all cells. Embryonic stem cells as well as induced
pluripotent stem cells do not show signs of replicative senescence
in long-term culture [53]. Loss of pluripotency seems to be
accompanied with limitation of replicative live span and this might
be governed by specific epigenetic modifications. We have
previously demonstrated continuous changes in gene expression
profiles of MSC upon long-term culture [15,54] and observed a
moderate but significant concordance in the expression profiles
upon long-term culture in vitro and aging in vivo [16]. Furthermore,
we have shown that long-term culture of MSC induces hyper-
methylation and hypo-methylation at specific CpG sites and that
these epigenetic modifications are also related to those between
MSC from young and elderly donors [14]. Here, we have
exemplarily analyzed DNA methylation changes upon long-term
culture of fibroblasts and there was a striking concordance of
senescence-associated methylation changes in fibroblasts and
MSC. Additional fibroblast samples are currently culture-expand-
ed to further discern long-term culture associated DNA methyl-
ation changes. This might facilitate identification of specific CpG
sites for monitoring the replicative lifespan in cellular products for
therapeutic application [17]. Notably, there was also a significant
association of methylation changes upon long-term culture and
aging in fibroblasts. This indicates that both mechanisms might be
regulated by similar epigenetic modifications.
Two fundamental hypothesis are currently discussed to account
for aging: it might be evoked by stochastic or random, accidental
events, or it is a result of a purposeful program driven as
developmental process [55]. Most likely, interplay of both
mechanisms promotes aging at various levels. However, the highly
reproducible epigenetic modification at specific CpG sites in
developmental genes argues for a coordinated developmental
mechanism. This study demonstrates, that fibroblasts and MSC
maintain their positional memory as well as age-associated
epigenetic modifications even after in vitro culture. Age-associated
modifications seem to be regulated in a cell type specific manner.
Further research on other characterized cell preparations and
larger numbers of samples are important to gain insight into the
mechanisms that control DNA methylation at specific sites in the
genome.
Materials and Methods
Isolation of primary cells
Human dermal fibroblasts were isolated from skin samples
donated by young (6–23 years) and elderly (60–73 years) female
patients undergoing surgical interventions. All samples were taken
after written consent, using guidelines approved by the Ethic
Committee on the Use of Human Subjects at the University of
Aachen. Skin samples were treated with dispase II (Roche
Diagnostics, Mannheim, Germany) for 12 hours at 4uCt o
separate the dermis from the epidermis. The dermis was digested
with 0,2% collagenase and 1,5% BSA in collagenase buffer
(100 mM HEPES, 120 mM NaCl, 50 mM KCl, 1 mM CaCl2,
5 mM Glucose) for 45 minutes. Dermal remnants were removed
by filtering the digest through a 100 mm nylon strainer (Falcon,
Becton Dickinson [BD], San Jose, USA). The cells were
subsequently washed and expanded in standard medium consist-
ing of DMEM (PAA; 1 g/L glucose) supplemented with glutamine
(PAA), penicillin/streptomycin (PAA) and 10% fetal calf serum
(Biochrom, Berlin, Germany) in a humidified atmosphere at 5%
CO2.
Mesenchymal stromal cells were isolated from human bone
marrow after written consent using guidelines approved by the
Ethic Committee on the Use of Human Subjects at the University
of Heidelberg as described before [16]. In brief, MSC were
isolated from bone marrow aspirates from the iliac crest of young
healthy donors for allogeneic transplantation or from the caput
femoris after hip fracture of elderly donors. MSC were culture-
expanded in culture medium M1 as previously described [16,30].
Immunophenotypic analysis
Surface marker expression was analyzed on a FACS canto II
(BD) upon staining with the following antibodies as described
before [16]: CD14-allophycocyanin (APC, clone M5E2, BD),
CD29-phycoerythrin (PE, clone MAR4, BD), CD31-PE (clone
WM59, BD), CD34-APC (clone 8G12, BD), CD45-APC (clone
HI30, BD), CD73-PE (clone AD2, BD), CD90-APC (clone 5E10,
BD), CD105-fluorescein isothiocyanate (FITC, clone MEM-226,
ImmunoTools, Friesoythe, Germany).
In vitro differentiation
Osteogenic, adipogenic and chondrogenic differentiation of
fibroblasts and MSC was simultaneously performed under the
same differentiation conditions as described before [15,56]. After
three weeks, osteogenic differentiation was analyzed by Alizarin
Red staining and quantified with a method based on acetic acid
extraction and neutralization with ammonium hydroxide [57]. A
Tecan infinite M200 plate reader was employed to measure the
absorbance at 405 nm.
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cent dye BODIPY (4,4-difluoro-1,2,5,7,8-pentamethyl-4-bora-
3a,4a-diaza-s-indacene) and counter-stained with DAPI (49,6-
Diamidin-2-phenylindol; both Molecular Probes, Eugene, Ore-
gon, USA). Fluorescence microscopic pictures were always taken
from four randomly chosen areas with a Leica DM IL HC
microscope (Leica, Wetzlar, Germany). Cell nuclei and BODIPY
positive cells were counted with ImageJ software (rsbweb.nih.gov/
ij/) to determine the percentage of cells that differentiated towards
adipogenic lineage as described before [58].
Chondrogenic differentiation was induced in micromass culture
for three weeks. Subsequently the pellets were fixed with 10%
formalin and paraffin embedded. 1 mm sections were stained with
Alcian blue in combination with PAS (Periodic acid-Schiff) in an
automated slide stainer and photo-documented.
DNA isolation
Genomic DNA was isolated from 10
6 cells using the QIAGEN
DNA Blood Midi-Kit. DNA quality was assessed with a
NanoDrop ND-1000 spectrometer (NanoDrop Technologies,
Wilmigton, USA) and gel electrophoresis. 600 ng DNA were
subsequently bisulfite converted using the EpiTect Bisulfite Kit
(Qiagen, Hilden, Germany).
DNA methylation profiling
DNA methylation profiles were analyzed using the Human-
Methylation27 BeadChip (Illumina, San Diego, USA) as described
before [14]. About 200 ng of bisulfite converted DNA were
applied per BeadChip according to the manufacturer’s instruc-
tions. During hybridization, the DNA molecules anneal to two
different bead types with locus-specific DNA oligomers - one
corresponds to the methylated (C) and the other to the
unmethylated (T) state. Allele-specific primer annealing is followed
by single-base extension using DNP- and Biotin-labeled ddNTPs.
After extension, the array is fluorescently stained, scanned, and the
intensities of the unmethylated and methylated bead types
measured. Hybridization and initial data analysis with the
BeadStudio Methylation Module was performed at the DKFZ
Gene Core Facility in Heidelberg. The precise distribution of
samples across the beadchips is presented in Table S3. The
complete CpG methylation values have been deposited in NCBIs
Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/
geo/) and are accessible through GEO Series accession number
GSE22595. (Hyperlink for review: http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?token=rbsjfkqoqoukstc&acc=GSE22595).
DNA methylation values, described as beta values, are recorded
for each locus in each sample. Background normalized raw data
were only used to compare the overall methylation level in samples
from young and elderly donors. For all other analysis, quantile
normalization of the raw data was performed to minimize the chip
effect [59]. Hierarchical clustering by Euclidian distance was
performed using the MultiExperiment Viewer (MeV, TM4) [60].
Principal components analysis (PCA) was calculated with prcomp
in R package stats. For analysis of age-associated DNA
methylation changes we have calculated mean methylation of
samples from young and elderly donors. To focus on biologically
relevant CpG sites we have selected those with differences in
average beta value greater than 0.15 (more than 15% difference in
methylation level). Standard deviation in DNA-methylation
measurements are not uniformly distributed across the range of
beta values – it has a parabolic shape with the maximum peak
around 0.5 [61]. Smaller changes at the two extremes of the beta-
scale might also be important but they are less likely to be
biologically relevant, more difficult to validate and using the 15%
methylation threshold reduces beadchip effects which might exist
despite quantile normalization.
To further select for significantly differentially methylated CpG
sites we used a false discovery (FDR) approach using limma
moderated T-test, which is based on an empirical Bayes
moderation approach [62]. For comparison of fibroblasts and
MSC we used very stringent parameters with 15% methylation
changes and adjusted p-value (q-value) ,0.001 [61]. However,
these criteria were too stringent for analysis of aging in fibroblast
because of the relatively small number of samples and therefore,
we used an additional non-parametric method named RankProd
with q-value ,0.05. This method shared many CpG sites with the
above mentioned cut-off of 15% methylation change. Genes
associated with the differentially methylated CpG sites were
classified by GeneOntology analysis using GoMiner software
(http://discover.nci.nih.gov/gominer/).
Pyrosequencing
Methylation changes in CDKN2B were validated by pyrose-
quencing as described before [14]. Pyrosequencing was performed
at Varionostic GmbH (Ulm, Germany).
Quantitative real-time PCR analysis
Expression of 7 differentially methylated genes was analyzed by
real-time quantitative PCR (qRT-PCR) using the StepOne
TM
Instrument (Applied Biosystems, Applera Deutschland GmbH,
Darmstadt, Germany). Total RNA was isolated and reversely
transcribed as described in our previous work [16]. Primers were
obtained from Metabion (Martinsried, Germany) (Table S4).
QRT-PCR reactions were performed with the Fast SYBRH green
PCR master mix in a MicroAmp optical 96-well reaction plate
according to the manufacturer’s instructions (Applied Biosystems).
Gene expression levels were normalized to GAPDH expression.
Statistics
All results are expressed as mean 6 standard deviation. To
estimate the probability of differences we have adopted the two-
sided Student’s T-test. Probability value of P,0.05 denoted
statistical significance. Probability that age-associated methylation
changes are related in different datasets was estimated by
hypergeometric distribution, and linear correlation was deter-
mined by Pearson correlation coefficient. Representation of
differentially methylated genes in functional categories was
analyzed by Fischer’s Exact p-value.
Supporting Information
Figure S1 Histograms of limma moderated T-test raw
p-values. For comparison of fibroblasts of young versus elderly
donors, we performed nonspecific filtering to exclude the CpG
sites with low variation by applying nsFilter function in genefilter
package in R/Bioconductor. We then compared the histograms of
raw p-values before and after filtering. This shows that the non-
specific step can improve our analysis.
(JPG)
Figure S2 Gene Onthology analysis of genes with
differentially methylated CpG sites between fibroblasts
and MSC.
(TIF)
Figure S3 Heat map of CpG sites which lead to
clustering according to sampling location. Samples were
classified according to their sampling location (iliac crest, caput
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sites were selected that might be differentially methylated
(P,0,001; limma moderated F-statistic). These CpG sites were
then subjected to a heatmap. Each CpG was normalized to zero
and unit standard deviation.
(JPG)
Figure S4 Hierarchical clustering of 85 CpG sites
associated with the four HOX clusters.
(TIF)
Figure S5 qRT-PCR of differentially methylated genes
in fibroblasts of young and elderly donors.
(TIF)
Figure S6 Boxplot of methylation level in raw data of
beadchips.
(TIF)
Table S1 Age-associated methylation changes in fibro-
blasts.
(DOC)
Table S2 Age-associated changes in fibroblasts and
MSC.
(DOC)
Table S3 Distribution of all the samples across the
beadchips.
(DOC)
Table S4 Primer sequences for qRT-PCR.
(DOC)
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